Objective To compare bladder sensitivity between patients with pelvic pain and patients who were pain free, undergoing noninvasive, controlled bladder distension via diuresis. We also sought to measure potential mechanisms underlying bladder sensitivity.
Introduction
Painful bladder syndrome/interstitial cystitis (PBS) is a poorly understood chronic pain state arising in part from an amalgam of disrupted peripheral and central pain regulatory circuits. As few treatments are consistently effective, preventative strategies are urgently needed. A well-recognised finding in PBS is increased bladder pain with bladder filling. 1 Although self-reporting distress in PBS appears to reflect both urgency/frequency [the International Continence Society (ICS) terms this increased bladder sensation) and pain, the physiological basis for these dual contributions is not precisely known. 2 In a preliminary study, during a standardised cystometry task, PBS patients report prolonged and more intense discomfort compared with healthy controls. 3 The induction of pain at low filling volumes in patients with PBS parallels findings showing that many patients with irritable bowel syndrome also report pain at lower distension pressures during anal manometry. 4 In functional bowel disorders, standard assays of visceral hyperalgesia are well-recognised research tools, and have been used to characterise the relevant nerve pathways and molecular underpinnings of these symptoms. 5, 6 Targeting the bladder for visceral pain testing is limited by discomfort from urethral catheterisation and the risk of infection. Validating more comfortable, non-invasive tests could enhance research participation.
The present study extends our prior studies of non-invasive bladder distension in studying menstrual pain and cross-organ visceral sensitivity in otherwise healthy controls, with the objective of determining whether bladder distension pain differs between CPP and PBS patients (versus healthy controls). 7 As patients with PBS have widespread reduced pain tolerance and report more somatic symptoms, we also explored secondarily whether non-specific factors and psychological distress might affect experimental bladder pain testing. 1, 8 In particular, we specifically assessed whether pelvic floor sensitivity predicts bladder distension pain, as pelvic physical therapy reduces bladder pain symptoms, but the underlying mechanism for this efficacy is unknown. 9 
Methods

Overview
This study was a planned analysis for one aim of an overall study of pelvic floor function and bladder pain sensitivity. We prospectively recruited patients with chronic pelvic pain (CPP) and PBS, as well as pain-free controls, for a cross-sectional study at Evanston Hospital (Evanston, Illinois, USA) between July 2010 and September 2013 through nearby clinics and community advertisements.
Participants
Chronic pelvic pain (CPP) was defined as pain lasting for 3 months or longer in the area between the umbilicus and the inguinal ligament. Symptoms could not solely be perceived on the skin, only involve the hip or back, or only occur with menses. Patients with PBS were defined by the International Continence Society (ICS) criteria: complaint of pelvic pain related to bladder function, accompanied by other symptoms, such as increased daytime and night-time frequency, in the absence of proven urinary infection or other obvious pathology, with reported urgency or frequency symptoms.
2 Controls were free of pelvic pain, agematched with patients in the PBS cohort (AE5 years), and recruited from the same population. Cases were limited to ages 18-55 years old. Exclusion criteria included: pregnancy, active urogenital infection, prior urogenital malignancy, unexplained haematuria, active nephro/ ureterolithiasis, vaginal prolapse exceeding second degree, and unwillingness to avoid short-acting opioids prior to examination. All participants received modest stipends. The NorthShore University HealthSystem Institutional Review Board approved the study, and all participants gave informed consent.
Study procedure
All examinations and tests were performed in a research examination room. Participants were asked to complete a screen visit and two assessment visits.
Screen visit
All participants signed consent before any study procedures were executed. A complete abdominopelvic examination was performed by the primary author. The exam included asking participants to rate pain from palpation at multiple sites using a rating scale of 0-10 (0, no pain; 10, worst imaginable pain). Vaginal tissue compliance, voluntary pelvic floor contractility, and pelvic floor gross muscle strength were quantified on exam using Likert scales (see Appendix S1). Participants also completed the O'LearySant Interstitial Cystitis Symptom Index (ICSI) and Interstitial Cystitis Problem Index (ICPI), as well as University of Wisconsin (UW) interstitial cystitis questionnaires on bladder function. 10, 11 They also completed Patient Reported Outcomes Measurement Information System (PROMIS) computer adaptive tests for anxiety and depression. 12 A somatic symptom score was derived as the total score of non-bladder symptoms (dizziness, chest pain, nausea, feelings of suffocation, and tingling in fingers and toes), each rated on a Likert scale of 0-6 from selected UW reference scale questions, similar to those on the Brief Symptom Inventory assessing somatisation. 11 
Assessment visit 1
On the first assessment visit, external and internal pressurepain thresholds (PPTs) and bladder testing were performed using our published standardised protocols. 13 The order of PPT and bladder testing was randomised, except for the PBS participants, who all underwent bladder filling first. For PPT assessment, we first tested the four external sites (shoulder, forehead, hip, and knee), applying pressure at a rate of between 0.5 and 1.0 kg/cm 2 /s using a pain pressure algometer with a 1-cm 2 circular cap. The same approach was next applied to test four transvaginal pelvic floor sites (right and left iliococcygeus, anterior bladder, and posterior anorectal raphe) using a specially designed, fingertipmounted algometer. Averaged thresholds from two trials were used for the final analysis. Further details are presented in Appendix S1.
Participants were asked to drink 360 ml of water 1 hour before the visit and abstain from caffeine on the day of testing. After an initial void, participants had a baseline volume measurement of the bladder while supine. Bladder volume was measured using a Voluson 730 three-dimensional transabdominal 5.0-MHz ultrasound transducer (GE Healthcare, Wauwatosa, WI, USA). The measurement of bladder volumes was performed using the scanner's onboard VIRTUAL ORGAN COMPUTER-AIDED ANALYSIS (VOCAL TM ) software with the transducer oriented sagittally above the symphysis pubis. Volume was calculated from the perimeter measurements of six serial plane sections separated by 30°. The validation and reliability of this method has been reported upon previously by our research team. 7 Following the initial scan, participants were asked to drink 600 ml of water within 5 minutes to further encourage diuresis. While participating they were offered light reading and were asked not to do other distracting tasks such as making phone calls or engaging in regular conversation. Participants were asked to report awareness upon reaching three levels of bladder urgency: first sensation, first desire to void, and maximal capacity. At each of these three thresholds we measured bladder volume, and then asked the participant to rate their level of bladder pain and urgency (on a 1 0-cm visual analogue scale, VAS). The urgency scale was anchored at opposite ends with the descriptors 'no urgency' and 'worst urgency imaginable'. Similarly, the pain scale was anchored at opposite ends with the descriptors 'no pain' and 'worst pain imaginable'. Additionally, every 15 minutes from the time that participants finished drinking the priming dose of water, they were instructed to evaluate their current level of pain and urgency using the same VAS measures. If a participant did not reach maximum capacity by 45 and 60 minutes, she was asked to drink an additional 10 ml of water (with a maximum of 600 additional ml) to encourage diuresis. The bladder testing was capped at 2 hours. Bladder filling rates were estimated by calculating the change in volumes estimated at each cystometric threshold, divided by the elapsed time.
Assessment visit 2
This visit was conducted approximately 1 month after assessment visit 1. All participants underwent internal and external pressure testing and completed a similar battery of questionnaires, assessing pain levels and mental health, as was collected during the screening visit.
Study size
The study aim when the study was initially funded targeted a primary hypothesis that bladder sensation and pelvic floor sensitivity are positively associated. Prior published data suggested a Cohen's d effect size of 1.1 for this association. 1, 3, 14 A power analysis estimated that to achieve this effect size with 80% power, we would need 38 patients with CPP and/or with PBS (28 enhanced bladder sensation and ten with normal bladder sensation) to significantly resolve a group difference (P < 0.05). An additional aim was to assess whether there were differences in self-reported bladder sensation between pain groups and pain-free controls.
Statistical analysis
For this paper we addressed three primary predefined contrasts. Between diagnostic groups we compared bladder pain at maximum capacity and the variability over a time series, capturing the overall change in bladder pain during the experimental bladder task. We also compared the average pelvic floor pressure pain thresholds between patients with pain who exhibit lower versus higher first sensation thresholds (with a ≥ 100-mL cut-off).
14 We had complete case data for all bladder testing and accompanying ratings. Based on Shapiro-Wilk determinations of the normality of variables, group differences were evaluated with Wilcoxon rank-sum tests (followed by post hoc Dunn's tests with Holm-Sidak corrections for multiple comparisons), repeated-measures ANOVA on the ranks, or chi-square tests with STATA 13.0 (College Station, TX, USA). Relationships between bladder distension pain, somatic pain sensitivity, the ICSI, and other candidate contributing factors (pelvic floor tone, strength, flexibility, and voluntary control; anxiety; depression; and somatic symptoms) were analysed with Spearman rank-order correlation. Significant differences between correlation coefficients were verified with Fisher's z-transforms. To verify whether bladder distension pain or other factors were independently related to bladder pain phenotypes, we performed multivariate linear regression and determined receiver operating characteristic curves.
Results
Demographic profile
As expected, the PBS group reported higher bladder distress on both the UW and ICSI bladder-specific measures, compared with pain-free controls (P < 0.01; Table 1 ). Women with CPP had intermediate UW and ICSI scores that were significantly higher than in healthy controls, but lower than in participants with PBS (P < 0.05). Diary data supported that both CPP and PBS patients had more voids per day compared with healthy controls (P < 0.05). Consistent with prior published findings, both pain groups had significant duration of continuing symptoms, significant rates of co-morbid diagnoses (irritable bowel syndrome, endometriosis, fibromyalgia, abuse history), and heightened levels of depression and anxiety.
Bladder testing flow rate
An important consideration in replacing pain measurements obtained with retrograde bladder filling with natural diuresis is that different flow rates could affect sensation, or the reporting of pain. To determine the impact of natural variation in flow rate on perception we analysed empirical differences of average flow on sensation and pain. There were no significant differences in flow rate between the groups [healthy, 6.6 (5.6-8.0) ml/min; CPP, 6.6 (5.4-9.0) ml/min; PBS, 6.0 (5.0-6.8) mL/min; P = 0.45); however, there was a significant positive correlation between flow rate and maximum tolerance bladder volume (r = 0.73; P < 0.001). This is potentially linked to the fact that women with low bladder capacity drink less to improve tolerability. 15 Also, flow rates increased over time. Across all participants there was a significant increase in flow rate from first sensation [4.3 (2.5-6.6) ml/min] to first urge [6.9 (5.3-9.2) ml/min; P < 0.001], and again from first urge to maximum tolerance [8.7 (7.0-10.8) ml/min; P < 0.001]. To account for any potential confounding, we examined tolerances across the groups with a general linear model accounting for flow rate. In the general linear model, there was a significant effect of rate on maximum tolerance (P < 0.001), but women with PBS still had a 112 (44-181) ml lower volume at maximal capacity compared with women in the control or CPP groups (P < 0.001).
Controlled bladder filling elicits greater pain in women with PBS
Women with PBS reached all cystometric thresholds (first sensation, first desire to void, and maximal capacity) at significantly lower volumes and time-to-threshold than healthy controls ( Figure 1A ; Table S1 ; P < 0.05). The mean bladder volume and time-to-threshold was significantly lower in the PBS group compared with the CPP group at maximal capacity only. Volume and time-to-threshold at each cystometric threshold did not differ between CPP and healthy controls; however, women with CPP reported more pain than healthy controls at all sensory thresholds (Figure 1B ; Table S1 ; P < 0.05). Furthermore, women with PBS had higher bladder pain than those with CPP both at first sensation and first desire to void ( Figure 1B ; Table S1 ; P < 0.05).
The longitudinal report of bladder urgency and pain ratings are shown in Figure 1C -D, with a significant effect of both time and group observed (P < 0.001). Nested group 9 time interactions indicated that women with CPP have significant increasing pain over time, compared with healthy participants, and that women with PBS have worsening pain over time, compared with women with CPP (P < 0.001).
Potential factors influencing bladder volume tolerance and pain report
In our prior work, full data were not available to evaluate potential predictors of either evoked bladder pain or bladder volume sensitivity. We found some positive associations between pelvic floor mechanical sensitivity and evoked bladder pain report. Pressure pain threshold under the bladder and pain at first sensation was inversely correlated (Table 2 ; r = À0.46; P < 0.01). Pain evoked by clinical bladder exam was also correlated with bladder distension pain at all cystometric thresholds (r = 0.51-0.56; P < 0.01). All other PPTs (transvaginal or external), as well as pelvic floor anatomy and functional assessments (Table S2) , were not associated with bladder distension pain. For predictors of volume sensitivity, we had one planned comparison of average pelvic floor PPT for women with pain only, to determine whether mechanical sensitivity was higher in women with volume sensitivity. No differences in pressure thresholds were observed: for high volume sensitivity of <100 ml for first sensation [1.19 (1.00-1.44) kg/cm 2 ; n = 21] versus low volume sensitivity [1.00 (0.85-1.23) kg/cm 2 ; n = 25; p = 0.13]. Likewise, no significant associations were seen between any volume sensitivity threshold with any PPTs. As with pain, pelvic floor tone, strength, flexibility, and voluntary control did not predict volume sensitivity (Table S2) . Interestingly, reporting a prolonged duration of pain (aftersensation) following mechanical pressure testing (Table 2 ) correlated with both bladder distension pain (r = 0.50-0.55), first desire to void (r = 0.39), and maximal capacity volumes (r = 0.40, all P < 0.05).
Psychological factors have more impact on bladder symptom reporting than bladder distension pain Finally, we examined the associations of psychological factors and bladder distension pain or volume sensitivity (Table 2) . At first sensation, moderate positive correlations were observed between bladder distension pain, somatic symptom reporting, depression, and anxiety (0.4-0.48; P < 0.05), whereas depression correlated with bladder pain similarly for first urge and maximal capacity. We did not observe significant associations between volume sensitivity and psychological factors, just as we found with mechanical sensitivity and pelvic anatomy factors (Table S2) .
Associations between physiological constructs, psychological profiles, and disease-specific outcome measures
We also characterised how the combination of functional bladder pain, capacity, and psychosomatic factors influences bladder-specific symptom reporting in PBS. Maximal distension pain (r = 0.56), maximal capacity volume (r = -0.44), palpation evoked bladder pain (r = 0.60), and somatic symptoms (r = 0.59) were associated with clinical bladder symptomatology (ICSI; Table 2 ). Interestingly, the association of general somatic symptoms with bladder symptoms is stronger than its relationship with cystometric measures of sensitivity (maximal distension pain, r = 0.35; capacity, r = À0.18; P < 0.05; Fisher z-transform). We next explored the distribution of these variables for each group, to better understand the weight of bladder factors versus somatic symptoms. We plotted the summed standardised values for these three variables for each individual participant, adjusting for the general prevalence of CPP and PBS (Figure 2 ). Although significant bladder distension pain was rare in the general population, half of patients with CPP had bladder distension pain, but not necessarily accompanied by filling sensitivity. In patients with PBS, 19/ 23 had summed standardised scores for bladder pain, bladder sensation, and somatic symptoms that exceeded two standard deviations from median values of a general population; however, there was seemingly little relationship between the level of bladder pain or enhanced bladder sensation and somatic symptoms among patients with PBS. Multivariate linear regression further identifies that maximal capacity pain, bladder sensitivity, and somatic symptom reporting are each independent factors contributing to ICSI scores (Table S3 ; r 2 = 0.54; p < 0.001). A receiver operating characteristics curve showed that the three-factor model generated an area under the curve (AUC) of 0.90 for identifying participants with an ICSI score ≥6, the threshold for PBS diagnosis suggested in the original ICSI validation paper (Figure 2) . 10 The three-factor model was superior to a bladder factors-only model (AUC = 0.83; P < 0.05) or a somatic complaint-only model (AUC = 0.74; P < 0.01).
Discussion
Main findings
We applied a standardised protocol for measuring bladder pain and sensation, exploiting the simplicity of provoked diuresis, and confirm that distension-induced bladder pain is present in classic PBS as well as in half of patients with CPP not meeting PBS criteria. Our non-invasive measure empirically differentiates between relative degrees of visceral sensitivity (CPP versus PBS), and is less sensitive to nonspecific somatic/psychological factors. The simplicity of this measure could make it attractive as a general measure of visceral hypersensitivity, with research applications beyond the urological field. 5, 6 Another key finding was that pelvic floor pain sensitivity did not predict visceral sensitivity. Our original hypothesised relationship was based on previous clinical observations that targeted pelvic floor physical therapy can improve bladder pain symptoms and can reduce general pelvic floor sensitivity. 9, 16 In contrast, we found that localised mechanical hyperalgesia during palpation or vaginal pressure pain thresholds predicted bladder distension pain and sensation, but only at the bladder site. We can thus conclude that somatovisceral convergence is not a major contributory factor in bladder filling pain, yet pelvic floor dysfunction could still incrementally influence inputs to the brainstem, thereby reducing inhibition and increasing overall bladder pain symptomatology. 17 With as many as 43% of patients not significantly responding to manual therapy, and as questionnaire-based studies are vulnerable to somatisation, quantitative sensory evaluation of the bladder and pelvic floor may be necessary to elucidate the mechanisms that are modifiable through physical therapy. One likely possibility is that PBS represents heterogeneous groupings of patients, some with predominantly pelvic floor dysfunction, others mainly expressing dysfunctions in central pain processing, and still others exhibiting predominantly pure bladder mechanical hyperalgesia. 18 A factorial approach to untangling pain mechanisms has been used to identify which patients with diabetic neuropathy will respond to duloxetine, a drug also used off-label to treat PBS. 19 
Strengths
Several strengths of our study support diuresis-provoked bladder testing as a valid visceral sensitivity task. First, we controlled for sociodemographic features within a reproductive age cohort on bladder distension pain and found no influence. Our extensive demographic characterisation, including medical co-morbidities (endometriosis, dysmenorrhea, fibromyalgia, abuse exposure) will allow future studies to contrast their findings using these parameters, as our sample is typical of a referral population of women in significant distress. Second, we controlled for potential psychological confounding factors with standardised patient-reported outcome instruments, as studies of rectal distension have implied that heightened sensation is entirely mediated by anxiety or somatisation. 20, 21 This allowed us to show that bladder distension pain may be a less biased outcome measure, perhaps reflecting the lack of perceived threat (no catheter or manometry balloon insertion) presented by a noninvasive test. As self-reported symptom indices are vulnerable to somatisation and psychological factors, complete phenotypic assessment of pain states ideally includes symptom-based and unbiased experimental visceral pain assessment. 8, 22, 23 Third, we used a positive control group without significant bladder symptoms to untangle potential pain and urgency relationships on visceral pain sensitivity.
Limitations
The primary limitation of a naturalistic study is the inability to precisely control the experimental stimulus; however, when we controlled for estimated filling rates, we found no difference between diagnostic groups, and likewise no relationship to distension provoked pain. Although impairments in compliance accounting for limitations in maximal capacity are not associated with PBS, future studies using ultrasonographic elastography could confirm this non-invasively. 24, 25 We acknowledge this is a modest sized study, but we were adequately powered for our primary contrasts. The future replication of our results in larger cohorts is obviously needed.
Interpretation
How should we investigate the utility of distensionmediated pain as a risk marker for future PBS? We are still quite far from understanding the trajectory that leads from asymptomatic bladder sensitivity to overt bladder pain symptoms. Large-scale studies, like the continuing National Institutes of Health-funded Multidisciplinary Approach to Pelvic Pain network, and its predecessors, have not longitudinally characterised the changes in visceral pain sensitivity in healthy participants, perhaps because catheterisation elicits more apprehension and pain, particularly in younger populations. 26, 27 Our tool could be used to follow the transition to chronic bladder pain if employed following cases of acute cystitis, focusing selectively on patients exhibiting generalised somatic symptoms. Given that a key role has been identified for somatisation in temporomandibular joint disorder risk in a large-scale longitudinal study, assessing visceral sensitivity and somatisation simultaneously could be quite enlightening. 28 
Conclusion
We show preliminary validity for diuresis-induced bladder pain as a visceral pain measure reflecting local mechanical sensitivity. As an assessment tool for the mechanism-based study of CPP states, it may be less influenced by psychological factors than patient-reported outcomes. The benefit of our visceral distension measure remains to be fully appreciated, as this task can be studied in ambulatory settings, may be a marker for the emergence of PBS, and potentially can be employed in therapeutic trials as an objective marker of disease change following treatment.
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